Quick summary
Camphor (Cinnamomum camphora) is an evergreen tree valued for its essential oil and aromatic properties. It has traditional medicinal uses and is investigated for diverse bioactivities including anti-inflammatory and antimicrobial effects. Current clinical evidence on camphor itself is limited, but it is often a component of polyherbal formulations studied for conditions such as chronic insomnia and respiratory symptoms. Research also addresses its safety profile, potential toxicity, and regulatory concerns for herbal products containing camphor.
What is it
Camphor is a naturally occurring compound extracted from the wood of the Cinnamomum camphora tree, an evergreen native to Asia. It has a strong aromatic scent and is commonly used in essential oils, topical applications, and traditional remedies.
Traditional uses
Traditionally, camphor has been used for its aromatic and medicinal properties, including relief of respiratory ailments, pain, and inflammation. It is also incorporated in remedies aimed at improving sleep and treating cough and cold symptoms.
Active compounds
The primary active compound in camphor is camphor itself, found in the essential oil of the tree. Related components in camphor-containing oils include terpinen-4-ol, which has been linked to anti-inflammatory effects. Camphor also modulates transient receptor potential (TRP) ion channels involved in sensory perception.
Potential benefits with evidence levels
- Sleep quality improvement for chronic insomnia
Evidence level: Human clinical evidence – randomized controlled trial
A 2026 randomized controlled trial compared a traditional Thai herbal remedy containing camphor with Cannabis sativa oil and lorazepam in adults with chronic insomnia. The herbal remedy showed significant improvement in sleep quality scores comparable to standard treatment, with mild adverse events reported. - Symptomatic relief in upper respiratory infections (cough and cold symptoms)
Evidence level: Preclinical and clinical evidence – mechanistic studies and reviews
Reviews indicate camphor’s ability to modulate TRP channels involved in pain, cough, and airway irritation. It inhibits TRPA1 and activates TRPM8 and TRPV1 channels, contributing to analgesic and cough-suppressant effects observed in over-the-counter remedies. - Anti-inflammatory activity
Evidence level: Preclinical evidence
Essential oils derived from camphor and related species show inhibition of inflammasomes and reduced pro-inflammatory cytokines in immune cells. Terpinen-4-ol is implicated in these effects. - Antimicrobial effects
Evidence level: Preclinical and ethnopharmacological evidence
Extracts of camphor have demonstrated antimicrobial activity in vitro against pathogens including methicillin-resistant Staphylococcus aureus and various fungal species. Camphor is used in polyherbal preparations showing antimicrobial potential.
Side effects
- Mild adverse events have been reported in some clinical trials of herbal remedies containing camphor, though details specific to camphor alone are limited.
- Potential toxicity related to concentration and route of administration is not well characterized in humans.
- Historical case studies suggest possible adverse effects with camphor-containing products, but current clinical data are lacking.
Drug interactions
No specific drug interaction data for camphor were identified in the available evidence. As with many herbal products, caution is advised due to potential interactions, although direct clinical evidence is lacking.
Who should avoid it
There are no well-documented contraindications specific to camphor from current clinical data. However, use during pregnancy and breastfeeding should be approached with caution due to insufficient safety evidence. Individuals with specific medical conditions should consult healthcare providers before use.
Evidence limitations
- Clinical trials specifically evaluating camphor monotherapy are scarce; most studies involve polyherbal formulations containing camphor.
- Safety data largely originate from literature reviews and regulatory dossiers rather than rigorous clinical safety trials.
- Preclinical studies provide mechanistic insights but do not establish confirmed clinical efficacy claims.
- Variability in formulations and product quality limits generalizability of findings.
- High-quality, large-scale randomized controlled trials focused on camphor are lacking.
- Data on drug interactions and contraindications are insufficient.
References
- Pakdee N, Sribunrieng N, Poowanna R. Integrative therapies for chronic insomnia: A randomized controlled trial of a traditional Thai Herbal Remedy and Cannabis sativa oil. 2026. Europe PMC. PMID: 41623556.
- Stinson RJ, Morice AH, Sadofsky LR. Modulation of transient receptor potential (TRP) channels by plant derived substances used in over-the-counter cough and cold remedies. 2023. Europe PMC. PMID: 36755306.
- Mssusa AK, Holst L, Kagashe G, Maregesi S. Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study. 2023. Europe PMC. PMID: 37986124.
- Shabbir A, Parvinzadeh Gashti M. Camphor’s Therapeutic Uses and Potential Hazards: An In-Depth Review of Its Medicinal Applications. 2026. Europe PMC. PMCID: PMC12943631.
Last reviewed
June 2024
Disclaimer: This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before using herbal products, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking medications.